Hubro Therapeutics
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ullernchausséen 64-66, Oslo, Oslo, 0379,...Website
www.hubrotherapeutics.comRevenue
$9.5 MillionIndustry
ZI Rank: 1
About Hubro Therapeutics
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hubro Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Hubro Therapeutics
Hubro Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Hubro Therapeutics is spiking on competitors!
Product Launch: Get notified when Hubro Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Hubro Therapeutics had a recent Job posting/layoffs
Check if Hubro Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Hubro Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Hubro Therapeutics has new funding data
Recommended Actions
Find VP level buyers at Hubro Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hubro Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hubro Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hubro Therapeutics.
Hubro Therapeutics Tech Stack
A closer look at the technologies used by Hubro Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Hubro Therapeutics
Hubro Therapeutics's product candidates are novel neoantigen targeted cancer vaccines for activation of anti-cancer specific T cell immune responses. By providing increased levels of anti-cancer reactive T cells, and by combining with other immune-oncology treatments, it is Hubro Therapeutics's desire and strong hope to improve the lives of cancer... Read More
